EP Patent

EP3768257A4 — USE OF [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2-YL)ETHYL] CARBAMATE IN POLYTHERAPY

Assigned to SK Biopharmaceuticals Co Ltd · Expires 2022-01-12 · 4y expired

What this patent protects

Patent listed against Xcopri.

Drugs covered by this patent

Patent Metadata

Patent number
EP3768257A4
Jurisdiction
EP
Classification
—
Expires
2022-01-12
Drug substance claim
No
Drug product claim
No
Assignee
SK Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.